NDLI: ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?

Content Provider	PubMed Central
Author	Robert, Kalyesubula Peace, Bagasha Perazella, Mark A.
Copyright Year	2014
Abstract	Contrast-induced nephropathy (CIN) is now one of the three leading causes of acute kidney injury in the world. A lot is known about the risk factors of CIN, yet it remains a major cause of morbidity, end stage renal disease, prolonged hospital stay, and increased costs as well as a high mortality. Many patients undergoing contrast-based radiological investigations are treated with angiotensin converting inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) for their cardiac and renal benefits and their known mortality benefits. However, controversy exists among clinicians as to whether ACE-Is and ARBs should be continued or discontinued prior to contrast media exposure. In this paper we review the current evidence on ACE-I/ARB therapy for patients undergoing procedures involving use of contrast media and provide recommendations as to whether these drugs should be continued or held prior to contrast exposure.
Related Links	http://dx.doi.org/10.1155/2014/423848
Starting Page	423848
File Format	PDF
ISSN	23146133
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2014
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2014-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Spermicide by females: what should males do?

Amylenes Do Not Lead to Bacterial Mutagenicity in Contrast to Structurally Related Epoxides

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Early Repolarisation – What Should the Clinician Do?

Contrast Enhanced Ultrasound of the Kidneys: What Is It Capable of?

What does the clinician need to improve patient care in systemic sclerosis?

Changes in Frequency-Doubling Perimetry in Patients with Type I Diabetes prior to Retinopathy

A letter to the Master Clinician

What the 7th Grader Should Know About Microbes — Or, Is That “What the College Student Should Know?”

ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?

Similar Documents

Spermicide by females: what should males do?

Amylenes Do Not Lead to Bacterial Mutagenicity in Contrast to Structurally Related Epoxides

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Early Repolarisation – What Should the Clinician Do?

Contrast Enhanced Ultrasound of the Kidneys: What Is It Capable of?

What does the clinician need to improve patient care in systemic sclerosis?

Changes in Frequency-Doubling Perimetry in Patients with Type I Diabetes prior to Retinopathy

A letter to the Master Clinician

What the 7th Grader Should Know About Microbes — Or, Is That “What the College Student Should Know?”

ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?